ESR1 and cancer: Of the five commonly accepted subtypes, HR+ luminal A and B cancers exhibit a profile similar to that of mature ER+PR+ luminal cells, although luminal B has a stronger proliferative signature (Cheang et al, 2009; Nielsen et al, 2010; Prat & Perou, 2011).